168 related articles for article (PubMed ID: 25208763)
1. TLR2 and TLR4 gene expression levels and associated factors during acute attack and attack-free periods in familial Mediterranean fever.
Karakose MZ; Yapali S; Salman E; Aksu K; Karakose S; Akarca US
Clin Rheumatol; 2015 Apr; 34(4):785-90. PubMed ID: 25208763
[TBL] [Abstract][Full Text] [Related]
2. Activated phenotype of circulating neutrophils in familial Mediterranean fever.
Manukyan G; Petrek M; Kriegova E; Ghazaryan K; Fillerova R; Boyajyan A
Immunobiology; 2013 Jun; 218(6):892-8. PubMed ID: 23182715
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 is overexpressed in Familial Mediterranean fever patients and is inhibited by colchicine treatment.
Ben-David H; Livneh A; Lidar M; Feld O; Haj Yahia S; Grossman C; Ben-Zvi I
Best Pract Res Clin Rheumatol; 2018 Oct; 32(5):651-661. PubMed ID: 31203923
[TBL] [Abstract][Full Text] [Related]
4. TLR2 and TLR4 polymorphisms in familial Mediterranean fever.
Speletas M; Kalala F; Mitroulis I; Papadopoulos V; Merentiti V; Germenis AE; Ritis K
Hum Immunol; 2009 Sep; 70(9):750-3. PubMed ID: 19445990
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack-free period.
Salimov A; Akyol U; Cildir B; Batu ED; Ozen S
Int J Pediatr Otorhinolaryngol; 2019 Apr; 119():185-192. PubMed ID: 30743166
[TBL] [Abstract][Full Text] [Related]
6. Plasma and platelet serotonin levels in familial Mediterranean fever.
Onat AM; Ozçakar L; Oztürk MA; Uçar G; Ureten K; Dagli N; Kiraz S; Ertenli I; Calgüneri M
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S16-20. PubMed ID: 17949546
[TBL] [Abstract][Full Text] [Related]
7. Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever.
Kisacik B; Akdogan A; Yilmaz G; Karadag O; Yilmaz FM; Koklu S; Yuksel O; Ertenli AI; Kiraz S
Eur J Intern Med; 2009 Jan; 20(1):44-7. PubMed ID: 19237091
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pentraxin-3 in familial Mediterranean fever patients during attack and attack-free periods.
Gok M; Sirkeci O; Kara M; Sakin YS; Tanoglu A; Sirkeci EE; Oztin H; Duzenli T; Kaplan M; Yazgan Y; Ipcioglu OM
Bratisl Lek Listy; 2018; 119(8):490-493. PubMed ID: 30160156
[TBL] [Abstract][Full Text] [Related]
9. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
[TBL] [Abstract][Full Text] [Related]
10. TLR polymorphisms in FMF: association of TLR-2 (Arg753Gln) and TLR-4 (Asp299Gly, Thre399Ile) polymorphisms and myeloid cell TLR-2 and TLR-4 expression with the development of secondary amyloidosis in FMF.
Soylu A; Ateş H; Cingöz S; Türkmen M; Demir BK; Tunca M; Sakızlı M; Cirit M; Ersoy R; Ulgenalp A; Kavukçu S
Inflammation; 2011 Oct; 34(5):379-87. PubMed ID: 20714796
[TBL] [Abstract][Full Text] [Related]
11. The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.
Çakan M; Karadağ ŞG; Tanatar A; Sönmez HE; Ayaz NA
J Clin Rheumatol; 2021 Jan; 27(1):1-4. PubMed ID: 31524848
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic insights into Familial Mediterranean Fever: Increased RGS10 expression and histone modifications accompanies inflammation in familial Mediterranean fever disease.
Caldiran F; Deveci K; Cacan E
Gene; 2024 May; 906():148222. PubMed ID: 38331118
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic validity of colchicine in patients with Familial Mediterranean fever.
Ozaltin F; Bilginer Y; Gülhan B; Bajin I; Erdogan O; Hayran M; Yılmaz E; Ozen S
Clin Rheumatol; 2014 Jul; 33(7):969-74. PubMed ID: 24740462
[TBL] [Abstract][Full Text] [Related]
14. Plasma nitric oxide level in familial Mediterranean fever and its modulations by Immuno-Guard.
Panossian A; Hambartsumyan M; Panosyan L; Abrahamyan H; Mamikonyan G; Gabrielyan E; Amaryan G; Astvatsatryan V; Wikman G
Nitric Oxide; 2003 Sep; 9(2):103-10. PubMed ID: 14623176
[TBL] [Abstract][Full Text] [Related]
15. Familial Mediterranean fever in children presenting with attacks of fever alone.
Padeh S; Livneh A; Pras E; Shinar Y; Lidar M; Feld O; Berkun Y
J Rheumatol; 2010 Apr; 37(4):865-9. PubMed ID: 20194447
[TBL] [Abstract][Full Text] [Related]
16. Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
Terekeci HM; Oktenli C; Ozgurtas T; Nalbant S; Top C; Celik S; Tapan S; Kucukardali Y; Sanisoglu YS; Solmazgul E; Sahan B; Sayan O
J Rheumatol; 2008 Oct; 35(10):2024-9. PubMed ID: 18785307
[TBL] [Abstract][Full Text] [Related]
17. Is Familial Mediterranean Fever a thrombotic disease or not?
Demirel A; Celkan T; Kasapcopur O; Bilgen H; Ozkan A; Apak H; Arisoy N; Yildiz I
Eur J Pediatr; 2008 Mar; 167(3):279-85. PubMed ID: 17436016
[TBL] [Abstract][Full Text] [Related]
18. Arg753Gln TLR-2 polymorphism in familial mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease.
Ozen S; Berdeli A; Türel B; Kutlay S; Yalcinkaya F; Arici M; Besbas N; Bakkaloglu A; Yilmaz E
J Rheumatol; 2006 Dec; 33(12):2498-500. PubMed ID: 17013994
[TBL] [Abstract][Full Text] [Related]
19. Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever.
Haznedaroglu S; Oztürk MA; Sancak B; Goker B; Onat AM; Bukan N; Ertenli I; Kiraz S; Calguneri M
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S77-80. PubMed ID: 16273770
[TBL] [Abstract][Full Text] [Related]
20. Higher thrombin activatable fibrinolysis inhibitor levels are associated with inflammation in attack-free familial Mediterranean fever patients.
Bavbek N; Ceri M; Akdeniz D; Kargili A; Duranay M; Erdemli K; Akcay A; Guz G
Ren Fail; 2014 Jun; 36(5):743-7. PubMed ID: 24580410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
